:660-6.
134. Patti G, Ricottini E, Nusca A, Colonna G, Pasceri V,
Dâ€™Ambrosio A, et al. Short-term, high-dose atorvastatin
pretreatment to prevent contrast-induced nephropathy in
patients with acute coronary syndromes undergoing
percutaneous coronary intervention (from the ARMYDACIN [atorvastatin for reduction of myocardial damage
